How does Mounjaro (tirzepatide) work for weight loss?
Mounjaro® is an injectable medication that is a combination GIP/GLP-1 receptor agonist. It mimics two hormones our body naturally makes- GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). GLP-1 acts on the pancreas to stimulate the release of insulin which lowers blood sugar and acts on the brain to decrease appetite and cravings. The addition of a GIP agonist to a GLP-1 agonist has been found to promote additional weight loss. Overall, Mounjaro prescriptions can decrease appetite and in combination with a low-calorie nutrition plan and increased physical activity can lead to weight loss. However, it is important to note that currently Mounjaro is only FDA-approved for the treatment of type 2 diabetes and not specifically for weight loss. Zepbound®, which contains the same active ingredient (tirzepatide) as Mounjaro, has been recently approved for the treatment of weight loss. Which medication you are prescribed depends on a variety of factors such as your insurance coverage, any medical conditions you may have, and which medication your healthcare provider determines to be appropriate for you.
Form Health
Form Health is a virtual obesity medicine clinic founded in 2019 that provides science-based obesity care to help patients achieve their weight loss and health goals. Patients have the opportunity to achieve sustainable weight loss by working closely with an American Board of Obesity Medicine physician and a Registered Dietitian who is a Board Certified Specialist in Obesity and Weight Management. Each Care Team develops a personalized treatment plan based on a comprehensive review of their medical history that includes behavioral support, nutrition, physical activity, and medication, if appropriate.
